In this proof-of-concept study, diverse T-lymphocyte derived cell line models of HIV infection, including latent infection models, were preferred over primary CD4+ T cells in which production and selection of HT1-expressing cells would be challenging. The gene discussed is CD4; the disease is HIV infectious disease.